SAM #36E79726R0022

Federal Procurement of Diltiazem 24Hr Capsules (AB3) for Multiple Agencies

This opportunity involves a large-scale federal procurement of Diltiazem 24Hr Capsules for distribution to multiple government healthcare agencies. - Government Buyer: - Department of Veterans Affairs (VA), National Acquisition Center (OPAL / National Acquisition Center, Hines, IL) - Serves VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center - Products Requested: - Diltiazem 24Hr Capsules (AB3, equivalent to Cardizem AB3) - 120mg, 180mg, 240mg, 300mg, and 360mg strengths - Each strength supplied in bottles of 90 capsules - Estimated annual quantities per strength: 45,597 (120mg), 38,296 (180mg), 33,861 (240mg), 5,982 (300mg), 6,769 (360mg) - Unique/Notable Requirements: - Each offeror must provide products with a unique National Drug Code (NDC) number and label - Open to all responsible sources able to supply the required pharmaceuticals (no specific OEMs named) - Contract period is one year with four one-year option periods - OEMs: - No specific OEMs or brand names required; products must be AB3-rated and equivalent to Cardizem - Place of Performance/Delivery: - Centralized at the VA National Acquisition Center in Hines, IL, with distribution to various federal healthcare facilities

Description

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0022 for an unrestricted procurement for Diltiazem 24Hr Capsules, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Solicitation #36E79726R0022 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about May 15, 2026, with a tentative closing date of June 1, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Chris Carthron. Questions can be e-mailed to Christopher.Carthron@va.gov. The estimated annual requirements are as follows:

REQUIREMENT DESCRIPTION ITEM DESCRIPTION PACKAGE SIZE (Bottles) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 DILTIAZEM (EQV-CARDIZEM AB3) 120MG 24HR CAP 90 45,597 2 DILTIAZEM (EQV-CARDIZEM AB3) 180MG 24HR CAP 90 38,296 3 DILTIAZEM (EQV-CARDIZEM AB3) 240MG 24HR CAP 90 33,861 4 DILTIAZEM (EQV-CARDIZEM AB3) 300MG 24HR CAP 90 5,982 5 DILTIAZEM (EQV-CARDIZEM AB3) 360MG 24HR CAP 90 6,769

View original listing